ZIM
ADMS

Zacks Investment Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Zacks Investment Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-45,273
Closed -$685K – 756
2016
Q2 		$685K Sell
45,273
-360
-0.8% -$5.93K 0.02% 399
2016
Q1 		$660K Buy
45,633
+10,797
+31% +$182K 0.02% 407
2015
Q4 		$987K Sell
34,836
-10,481
-23% -$176K 0.03% 294
2015
Q3 		$759K Buy
45,317
+5,302
+13% +$121K 0.03% 351
2015
Q2 		$1.05M Buy
+40,015
New +$778K 0.03% 278

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BS
Bow Street New York $52.4M AUM 2.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Zacks Investment Management's ADMS Position: Q3 2016 in Review

Zacks Investment Management sold out of Adamas Pharmaceuticals (ADMS) in Q3 2016, closing a stake of 45,273 shares — an estimated $685K sold.

Zacks Investment Management first reported a position in ADMS in Q2 2015 and held it in 5 quarters. The position peaked at $1.05M in Q2 2015. 81 funds tracked by Wall St. Rank hold ADMS as of Q3 2016.

  • Zacks Investment Management reported no remaining Adamas Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Zacks Investment Management sold 45,273 Adamas Pharmaceuticals shares in Q3 2016, an estimated $685K.
  • Zacks Investment Management first reported a position in Adamas Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Zacks Investment Management's Adamas Pharmaceuticals position peaked at $1.05M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2016.

Based on Zacks Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.